Brief: Bioventus Q3 Adjusted EPS USD 0.06
05/11/2024 12:30
Nov 05 (Reuters) - Bioventus Q3 sales USD 139 million. * Q3 adjusted EBITDA USD 23.6 million * outlook FY sales USD 562-567 million
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks